SCHEMBL230317

SCHEMBL230317

CCCCCCCCCCCC(=O)O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2OC(=O)CCCCCCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.56
NAAA Q02083 2/20 0.54
PRKCA P17252 6/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL227921 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL15073363 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL15073365 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL7000758 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL15073362 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL16681731 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL16752819 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL20213354 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL16681688 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL50126 1.00 BCHE (0.56) BCHENAAAPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588073-B1 COSMETIC COMPOSITION FOR THE NAILS AND USE OF AN ISOSORBIDE DERIVATIVE FIABILA (FR) 2017-06-14 EP claimed
US-9180317-B2 Cosmetic composition for nails and the use of an isosorbide derivative FIABILA (FR) 2015-11-10 US claimed
US-20120003166-A1 COSMETIC COMPOSITION FOR NAILS AND THE USE OF AN ISOSORBIDE DERIVATIVE FIABILA (FR) 2012-01-05 US claimed
US-9180317-B2 Cosmetic composition for nails and the use of an isosorbide derivative FIABILA (FR) 2015-11-10 US disclosed
US-20120003166-A1 COSMETIC COMPOSITION FOR NAILS AND THE USE OF AN ISOSORBIDE DERIVATIVE FIABILA (FR) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120003166-A1 COSMETIC COMPOSITION FOR NAILS AND THE USE OF AN ISOSORBIDE DERIVATIVE DPM1, POLR1C, SORD BCHE 4389/4885NAAA 4554/4885PRKCA 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.